×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ALGS – aligos therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ALGS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
06:00 am
algs
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
High
Report
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
4/14
04:05 pm
algs
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
High
Report
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation
3/27
07:25 am
algs
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Medium
Report
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
3/26
10:21 am
algs
Aligos Therapeutics (ALGS) is now covered by Westpark Capital. They set a "buy" rating and a $48.00 price target on the stock.
Low
Report
Aligos Therapeutics (ALGS) is now covered by Westpark Capital. They set a "buy" rating and a $48.00 price target on the stock.
3/20
08:07 am
algs
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
Medium
Report
Aligos Therapeutics (ALGS) was upgraded by Jefferies Financial Group Inc. to "strong-buy".
3/19
09:02 am
algs
Aligos Therapeutics (ALGS) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $48.00 price target on the stock.
Medium
Report
Aligos Therapeutics (ALGS) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $48.00 price target on the stock.
3/11
01:40 pm
algs
Aligos Therapeutics (ALGS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Medium
Report
Aligos Therapeutics (ALGS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
3/7
02:59 am
algs
Aligos Therapeutics (ALGS) was downgraded by Wall Street Zen from "ho
Medium
Report
Aligos Therapeutics (ALGS) was downgraded by Wall Street Zen from "ho
Date
Time
Symbol
Company Name
Action
%Chg
3/5/2026
08:00 am
algs
aligos therapeutics, inc. - common stock
BEAT
Report
-4.9%
aligos therapeutics, inc. - common stock
11/6/2025
08:30 am
algs
aligos therapeutics, inc. - common stock
MISS
Report
1.3%
aligos therapeutics, inc. - common stock
8/6/2025
04:05 pm
algs
aligos therapeutics, inc. - common stock
BEAT
Report
1.1%
aligos therapeutics, inc. - common stock
5/6/2025
08:00 am
algs
aligos therapeutics, inc. - common stock
BEAT
Report
-16.5%
aligos therapeutics, inc. - common stock
Date
Time
Symbol
Headline
Impact
4/14
04:18 pm
algs
Form 8-K Aligos Therapeutics, For: Apr 14
High
Report
Form 8-K Aligos Therapeutics, For: Apr 14
3/11
04:20 pm
algs
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Symons Julian A.
Low
Report
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Symons Julian A.
3/11
04:14 pm
algs
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Aneja Nikhil
Low
Report
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Aneja Nikhil
3/11
04:13 pm
algs
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: BLATT LAWRENCE
Low
Report
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: BLATT LAWRENCE
3/11
04:13 pm
algs
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Calhoun Lesley Ann
Low
Report
Form 4 Aligos Therapeutics, For: Mar 09 Filed by: Calhoun Lesley Ann
3/5
08:08 am
algs
Form 10-K Aligos Therapeutics, For: Dec 31
Medium
Report
Form 10-K Aligos Therapeutics, For: Dec 31
3/5
08:02 am
algs
Form 8-K Aligos Therapeutics, For: Mar 05
Medium
Report
Form 8-K Aligos Therapeutics, For: Mar 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: